Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?

L. G. Feun, N. Savaraj, P. Benedetto, S. Waldman, M. Collier, N. J. Clendennin

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.

Original languageEnglish (US)
Pages (from-to)448-451
Number of pages4
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume17
Issue number5
DOIs
StatePublished - Jan 1 1994

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Oral piritrexim in advanced bladder cancer: An effective drug after progression on MVAC chemotherapy?'. Together they form a unique fingerprint.

  • Cite this